2011
DOI: 10.1016/j.endoen.2011.04.001
|View full text |Cite
|
Sign up to set email alerts
|

Usefulness of genetic tests in familial hypocalciuric hypercalcemia with atypical clinical presentation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 35 publications
0
3
0
Order By: Relevance
“…Inactivating mutations in CaSR may affect a single allele (heterozygosis), resulting in the phenotype characteristic of FBHH, or both alleles (homozygosis or compound heterozygosis if no consanguinity exists), leading to NHPT, so that the degree of gene defect is responsible for the great difference in the phenotypic presentation [ 2 , 3 ]. In this report, two siblings had NHPT with homozygous mutations and variability in the degree of severity of symptoms In case 1 {(1V/12), ( Figure 1 )} the symptoms were severe in the face of high, but not too high PTH and extremely high calcium levels, while her younger sibling, case 2 {(1V/13), ( Figure 1 )} presented with milder symptoms, high calcium levels and extremely high levels of PTH.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Inactivating mutations in CaSR may affect a single allele (heterozygosis), resulting in the phenotype characteristic of FBHH, or both alleles (homozygosis or compound heterozygosis if no consanguinity exists), leading to NHPT, so that the degree of gene defect is responsible for the great difference in the phenotypic presentation [ 2 , 3 ]. In this report, two siblings had NHPT with homozygous mutations and variability in the degree of severity of symptoms In case 1 {(1V/12), ( Figure 1 )} the symptoms were severe in the face of high, but not too high PTH and extremely high calcium levels, while her younger sibling, case 2 {(1V/13), ( Figure 1 )} presented with milder symptoms, high calcium levels and extremely high levels of PTH.…”
Section: Discussionmentioning
confidence: 99%
“…Loss of functional mutations results in hypercalcemia with hypocalciuria. There are two forms, a heterozygous mutation resulting in a benign asymptomatic form not requiring treatment, called familial benign hypocalciuric hypercalcemia (FBHH) (OMIM #145980) typically characterized by moderate elevations of serum calcium concentration, inappropriately low urinary calcium excretion, and high normal or mildly elevated parathyroid hormone (PTH) levels [ 2 - 5 ]. The other being a homozygous mutation resulting in a more rare but severe form called neonatal hyperparathyroidism (NHPT) (OMIM # 239200) requiring urgent treatment.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation